The observed upregulation of DPEP3 and THRSP in high-grade tumors aligns with their established roles in tumor progression and metabolic reprogramming, while the downregulation of differentiation markers like KRT33A suggests a loss of epithelial characteristics in aggressive disease. The gene discussed is THRSP; the disease is neoplasm.